AndhraNews.net
Home » Business News » 2013 » September » September 26, 2013

For Ear Surgery, Unprecedented Visibility and Precision Are Now Available


September 26, 2013 - Yokneam, Israel

Lumenis Ltd., the world's largest medical laser company for surgical, ophthalmic and aesthetic applications, announces the launch of the new MicroLase Fiber and Otology kits, designed to expand use of the AcuPulse™ 40WG and AcuPulse™ DUO CO2 laser systems for ear surgery, and further improve ROI for hospitals and clinics. Based on physician input, the MicroLase Otology kits include two unique, single-use handpieces to give physicians easy access to all parts of the ear. The new smaller handpieces, with a 400 micron shaft tapering down to a 250 micron spot size, greatly improve visibility as well as reach to the middle ear anatomy.

"The precision and safety of the CO2 laser wavelength are unequivocal advantages in ear surgery. We are excited to have the MicroLase fiber and otology handpieces as they appear to bring this cutting edge technology exactly to the places that we need, allowing us to perform more sophisticated and demanding otology microsurgery procedures, such as stapedotomy," says Dr. Robert Vincent, Jean Causse Ear Clinic, Traverse de Béziers, France.

The MicroLase Otology kit significantly reduces the cost per procedure since its multi-use fiber can be used up to 25 times and it offers disposable tips. The MicroLase fiber is embedded with Lumenis' AcuPulse 40WG and AcuPulse DUO technologies, which deliver unmatched energy transmittance, critical for the low energy levels required in middle ear surgeries. The superior design of the Lumenis fiber is more efficient in transmission of the laser energy, enabling to get as close as possible to parity between the energy displayed on screen and the energy actually delivered to the patient.

In ear surgery, the microsurgical precision of the Lumenis CO2 laser makes it the ideal tool for safe and effective treatment of tiny and sensitive auditory structures. Studies have shown that physicians can attain comparable and often superior outcomes using CO2 lasers for ear surgery compared with other laser types and treatment modalities. (1,2,3)

"The CO2 laser wavelength is ideal for the delicate anatomy of the middle ear, so we are very pleased to expand our precision capabilities to otology," said Elad Benjamin, VP and General Manager of the Surgical Business Unit at Lumenis. "The ergonomic design of the MicroLase Otology handpieces provides unprecedented visibility and versatility to ENT surgeons. The reusable fibers with disposable tips help busy ENT practices save on sterilization time and cost per procedure."

About Lumenis

Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare. For more information about Lumenis and its products, please visit: www.lumenis.com.

Lumenis® and the Lumenis logo are trademarks or registered trademarks of Lumenis.
AcuPulse™, MicroLase™, Micro- G ™ and Micro- H™ are trademarks of Lumenis.

References:

1. Marchese MR, Scorpecci A, Cianfrone F, Paludetti G., "One-shot" CO2 versus Er:YAG laser stapedotomy: is the outcome the same?, Eur Arch Otorhinolaryngol. 2011 Mar;268(3):351-6. Epub.

2. Lesinski SG, Lasers for otosclerosis--which one if any and why, Lasers Surg Med. 1990;10(5):448-57.

3. Vernick DM, A comparison of the results of KTP and CO2 laser stapedotomy, Am J Otol. 1996 Mar;17(2):221-4.

4. Matković S, Kitanoski B, Malicević Z, Advantages of CO2 laser use in surgical management of otosclerosis, Vojnosanit Pregl. 2003 May-Jun;60(3):273-8.

5. Motta G, Moscillo L, Functional Results in Stapedotomy with and without CO2 Laser, ORL J Otorhinolaryngol Relat Spec. 2002 Sep-Oct;64(5):307-10.

6. Jovanovic S. Technical and clinical aspects of "one-shot" CO(2) laser stapedotomy. Advances in oto-rhino-laryngology. 2007;65:255-66. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17245056.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2416054
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2416056

Add to Digg Bookmark with del.icio.us Add to Newsvine

For Further Information:
Jeff Jacomowitz
Lazar Partners Ltd.
(212) 867 1762
jrjacomowitz@lazarpartners.com

MarketWire

Comment on this story

Share